Concepedia

Evaluation of neutralizing antibodies after vaccine BNT162b2: Preliminary data

Maria Teresa Vietri, Luisa Albanese, Luana Passariello, Giovanna D’Elia, Gemma Caliendo, Anna Maria Molinari, Italo Francesco Angelillo

Journal of Clinical Virology · 2021 · 10 citations · 8 references

DOIFull text

Open access

Concepts

References

8

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.5K citations · Full text

, , +17

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Zijun Wang, Fabian Schmidt, Yiska Weisblum et al. · Nature · 2021 · 1.5K citations · Full text

, , +17

Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021

Tamara Pilishvili, Katherine E. Fleming-Dutra, Jennifer L. Farrar et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 210 citations · Full text

, , +17

Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine

Florian Krammer, Komal Srivastava · medRxiv · 2021 · 131 citations · Full text

, , +16

Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers

Andrea Padoan, Luigi Dall’Olmo, Foscarina Della Rocca et al. · Clinica Chimica Acta · 2021 · 93 citations · Full text

, , +4